Cationic Albumin Nanoparticles for Enhanced Drug Delivery to Treat Breast Cancer: Preparation and In Vitro Assessment
Open Access
- 8 December 2012
- journal article
- research article
- Published by Hindawi Limited in Journal of Drug Delivery
- Vol. 2012, 1-8
- https://doi.org/10.1155/2012/686108
Abstract
Most anticancer drugs are greatly limited by the serious side effects that they cause. Doxorubicin (DOX) is an antineoplastic agent, commonly used against breast cancer. However, it may lead to irreversible cardiotoxicity, which could even result in congestive heart failure. In order to avoid these harmful side effects to the patients and to improve the therapeutic efficacy of doxorubicin, we developed DOX-loaded polyethylenimine- (PEI-) enhanced human serum albumin (HSA) nanoparticles. The formed nanoparticles were ~137 nm in size with a surface zeta potential of ~+15 mV, prepared using 20 μg of PEI added per mg of HSA. Cytotoxicity was not observed with empty PEI-enhanced HSA nanoparticles, formed with low-molecular weight (25 kDa) PEI, indicating biocompatibility and safety of the nanoparticle formulation. Under optimized transfection conditions, approximately 80% of cells were transfected with HSA nanoparticles containing tetramethylrhodamine-conjugated bovine serum albumin. Conclusively, PEI-enhanced HSA nanoparticles show potential for developing into an effective carrier for anticancer drugs.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP 93641)
This publication has 43 references indexed in Scilit:
- Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cellsInternational Journal of Nanomedicine, 2011
- Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisInternational Journal of Nanomedicine, 2010
- Advances in Novel Drug Delivery Strategies for Breast Cancer TherapyArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2010
- PEGylated PLGA nanoparticles for the improved delivery of doxorubicinNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticlesBiomaterials, 2009
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Investigation of the Interactions between Ligand-Stabilized Gold Nanoparticles and Polyelectrolyte Multilayer FilmsChemistry of Materials, 2005
- Potential of Albumin Nanoparticles as Carriers for Interferon GammaDrug Development and Industrial Pharmacy, 2005
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in cultureEuropean Journal of Cancer, 1994
- Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical resultsJournal of the American College of Cardiology, 1990